Impaired metabolism of polyamines in Parkinson’s disease as a potential target of the modern drug therapy
Parkinson’s disease (PD) is a disorder belonging to a large group of neurodegenerative diseases. One of the features of most of these disorders of the central nervous system (CNS) is the unknown pathogenesis. The same applies to PD. Recent studies show that abnormal polyamine biochemical changes in the CNS may cause neurotoxicity responsible for the development of PD. Read full text »
Videos
Pictures
Documents












